BS PHARM KOREA Co. Ltd., headquartered in Seoul, South Korea, is a pioneering wholesaler and manufacturer of medical products specializing in fillers, botulinum toxin, and skin boosters. The company prioritizes safety and quality, aiming to deliver high-quality products to its clients worldwide. Dedicated to enhancing beauty and health, BS PHARM KOREA ensures customer satisfaction by carefully addressing client needs and adhering to a customer-centric philosophy.
BS PHARM KOREA has built its reputation through its signature product lines, including the "EVE Series," "EXOGEN," "U:GEN," and "PLANITI." Among these, the EVE Series stands out as a comprehensive solution for various aesthetic purposes such as skin rejuvenation, lifting, wrinkle reduction, and brightening. EVETOX, a vacuum-dried Botulinum Toxin Type A product, offers enhanced safety and efficacy compared to conventional freeze-dried formulations. EVEHILO combines high and low molecular weight hyaluronic acid with succinic acid and peptides to deliver hydration, elasticity, and antioxidant benefits.

In addition to the EVE Series, BS PHARM KOREA’s De Beaute filler range has gained significant attention. Fill De Beaute, a hyaluronic acid-based filler, is designed to eliminate wrinkles with stable, long-lasting results. Rouge De Beaute, a lip-specific filler enriched with anthocyanins, enhances lip volume and adds vibrancy, earning widespread acclaim in global markets.

BS PHARM KOREA exports to over 30 countries, with major markets including Russia, Vietnam, the UK, the US, Thailand, and Turkey. The company's 2023 export revenue exceeded USD 15,148,048, with its products being widely used in leading clinics across Russia and Vietnam. Through participation in KIMES 2025, the company aims to establish partnerships in North and South America while expanding its global market share and visibility.
Looking ahead, BS PHARM KOREA plans to release two innovative products in the first half of 2025. Lipolysis is a slimming solution designed to reduce body fat and contour the body, while PLLACELL is a skin booster containing poly-L-lactic acid (PLLA), glutathione, polynucleotide, vitamin C, and sodium hyaluronate to enhance skin elasticity, hydration, and brightness. Both products reflect BS PHARM KOREA's dedication to innovation and its commitment to meeting diverse client needs.
BS PHARM KOREA will also host educational sessions and factory tours for physicians from Russia and Kazakhstan, showcasing its products and expertise to build trust and reinforce its industry presence.
BS PHARM KOREA will participate in KIMES 2025, taking place from March 20 to 23 at COEX in Seoul, to present its cutting-edge products and further solidify its position in the global medical aesthetic market.